| Chiu CC, Huang SY, Shen WW and Su KP |
------>authors3_c= ------>paper_class1=1 ------>Impact_Factor=8.286 ------>paper_class3=2 ------>paper_class2=4 ------>vol=160 ------>confirm_bywho=sihuang ------>insert_bywho=sihuang ------>Jurnal_Rank=3.2 ------>authors4_c= ------>comm_author= ------>patent_EDate=None ------>authors5_c= ------>publish_day=1 ------>paper_class2Letter=None ------>page2= ------>medlineContent= ------>unit=J0400 ------>insert_date=20021001 ------>iam=2 ------>update_date= ------>author=??? ------>change_event=4 ------>ISSN= ------>authors_c= ------>score=50 ------>journal_name=Am J Psychi ------>paper_name=Omega-3 Fatty Acid Monotherapy for a Pregnant Patient with Major Depressive Disorder ------>confirm_date=20060829 ------>tch_id=085004 ------>pmid=14978781 ------>page1=385 ------>fullAbstract=Based on the putative relationship between depleted omega-3 fatty acids and postpartum depression, we initiated an open-label pilot study of omega-3 fatty acid supplementation with the aim of preventing postpartum depression. Euthymic pregnant females with a past history of depression in the postpartum period were started on 2960 mg of fish oil (1.4:1 eicosapentaenoic acid:docosahexaenoic acid) per day between the 34th to 36th week of pregnancy and assessed through 12 weeks postpartum. Four of seven participants had a depressive episode during the study period. No participants withdrew from the study due to adverse events. This preliminary, small, open-label pilot study failed to show promising results for the use of omega-3 fatty acid monotherapy beginning at 34 to 36 weeks gestation for the prevention of postpartum depression in patients with a prior postpartum depression history. Controlled studies are lacking. ------>tmu_sno=None ------>sno=5881 ------>authors2= ------>authors3= ------>authors4= ------>authors5= ------>authors6= ------>authors6_c= ------>authors=Chiu CC, Huang SY, Shen WW and Su KP ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c= ------>publish_area=0 ------>updateTitle=Omega-3 fatty acids for the prevention of postpartum depression: negative data from a preliminary, open-label pilot study. ------>language=2 ------>check_flag= ------>submit_date= ------>country=None ------>no=2 ------>patent_SDate=None ------>update_bywho= ------>publish_year=2003 ------>submit_flag= ------>publish_month=1 |